Skip to main content
OpenTrials
Completed

NCT Number: NCT04421859

Augmented Reality Mobile Application for Glaucoma Education in the South Bronx

A team at the National Healthcare Group Eye Institute in Singapore have developed an augmented reality mobile phone application, EyeCU, to simulate glaucoma progression and enhance understanding about the disease and its course. It is a bilingual (English/Spanish) application that is free-to-download on the Android and Apple app store. As eye care physicians in the South Bronx, the investigators are hopeful that the findings in this study can be extrapolated to our patients in the South Bronx, where poor health literacy, non-adherence to glaucoma medication and poor follow-up remains a large barrier. The investigators hope that by offering the simulation in both English and Spanish, the investigators will not only be able to improve our patients' understanding of glaucoma, but also improve glaucoma treatment adherence and assess our patient population's responsiveness to augmented reality as an educational platform.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

BronxCare Health System

The Bronx, New York, 10457, United States

About this study

Experimental design: Pilot cohort study

Data collection: Patient characteristics such as age, sex, ethnicity, preferred language, zip code, employment status, highest educational attainment, current topical eye medications, Past Ocular History, Past Medical History

Recruitment for participation in the study will be performed during glaucoma clinic registration Consent will be conducted by a member of the research team who is not directly involved in the participant's clinical care Pre-intervention glaucoma knowledge questionnaire (NEHEP glaucoma knowledge questionnaire) will be given to participants, to be completed on dedicated clinic tablet device.

Post-intervention glaucoma knowledge questionnaire (NEHEP glaucoma knowledge questionnaire) will be given to participants, to be completed on dedicated clinic tablet device.

Rate of missed glaucoma follow-up appointments before and 6 months after application use will be collected from the electronic medical record.

Rate of medication adherence before and 6 months after application use will be collected from the electronic medical record.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a clinical diagnosis of glaucoma on medical therapy for at least 4 months

Exclusion criteria

  • Patients with optic neuropathies unrelated to glaucoma
  • Patients with VA 20/100 or worse in both eyes
  • Visual defects involving fixation in both eyes
  • Patients with symptoms impairing ability to operate a smartphone during visit including diplopia, motor difficulties, cognitive impairment, illiteracy
  • Patients who are unable to read or understand English or Spanish

Treatment and study plan

EyeCU Mobile Application

Other

Augmented reality glaucoma education mobile phone application

Primary outcomes

  1. Change in Questionnaire Scores

    Time frame: From date of intervention to date of post-intervention NEHEP glaucoma knowledge test, assessed up to 2 months

    Scores of pre- and post-intervention NEHEP glaucoma knowledge questionnaires will be compared

  2. Change in Follow Up Adherence

    Time frame: Before and 6 months after intervention

    Attendance rate at glaucoma follow-ups will be collected from electronic medical record

  3. Change in Medication Adherence

    Time frame: Before and 6 months after intervention

    Self-reported adherence to glaucoma medications will be collected from electronic medical record

Sponsors and collaborators

Lead sponsor

Bronx-Lebanon Hospital Center Health Care System

Other

Collaborators

  • EyeCU Group
  • VISRE

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jun 9, 2020
Registry last updated
Jul 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.